Search Results - "Poyah, Penelope"
-
1
Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease
Published in The Journal of clinical investigation (02-01-2018)“…Histone protein modifications control fate determination during normal development and dedifferentiation during disease. Here, we set out to determine the…”
Get full text
Journal Article -
2
The Impact of a New Triage and Booking System on Renal Clinic Wait Times
Published in Canadian journal of kidney health and disease (01-01-2020)“…Background: Prolonged wait times are known barriers to accessing nephrology care for patients needing more urgent specialist services. Improved process and…”
Get full text
Journal Article -
3
A Canadian Commentary on the NKF-ASN Task Force Recommendations on Reassessing the Inclusion of Race in Diagnosing Kidney Disease
Published in Kidney medicine (01-01-2024)“…In 2021, a committee was commissioned by the Canadian Society of Nephrology to comment on the 2021 National Kidney Foundation-American Society of Nephrology…”
Get full text
Journal Article -
4
Community pharmacists’ perspectives on assessing kidney function and medication dosing for patients with advanced chronic kidney disease: A qualitative study using the theoretical domains framework
Published in Canadian pharmacists journal (01-09-2023)“…Background: The kidneys are responsible for the elimination of many drugs. Chronic kidney disease (CKD) is common, and medications may require adjustment to…”
Get full text
Journal Article -
5
Primary Hyperoxaluria Type 1 (PH1) Presenting With End-Stage Kidney Disease and Cutaneous Manifestations in Adulthood: A Case Report
Published in Canadian journal of kidney health and disease (01-11-2021)“…Rationale: Primary hyperoxaluria (PH) is a rare autosomal recessive disorder more commonly diagnosed in children or adolescents. Owing to its rarity and…”
Get full text
Journal Article -
6
Renal-Limited Antiglomerular Basement Membrane Disease Related To Alemtuzumab: A Case Report
Published in Canadian journal of kidney health and disease (01-01-2020)“…Rationale: Alemtuzumab is a monoclonal antibody approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). Many autoimmune-mediated adverse…”
Get full text
Journal Article -
7
The Canadian Glomerulonephritis Registry (CGNR) and Translational Research Initiative: Rationale and Clinical Research Protocol
Published in Canadian journal of kidney health and disease (01-04-2022)“…Background: Glomerulonephritis (GN) is a leading cause of kidney failure and accounts for 20% of incident cases of end-stage kidney disease (ESKD) in Canada…”
Get full text
Journal Article -
8
Ascorbic Acid for Anemia Management in Hemodialysis Patients: A Systematic Review and Meta-analysis
Published in American journal of kidney diseases (01-12-2009)“…Background Ascorbic acid is believed to improve anemia in patients with end-stage renal disease, but its overall effectiveness is unclear. Study Design…”
Get full text
Journal Article -
9
Single cell G-protein coupled receptor profiling of activated kidney fibroblasts expressing transcription factor 21
Published in British journal of pharmacology (01-11-2023)“…Activated fibroblasts deposit fibrotic matrix in chronic kidney disease (CKD) and G-protein coupled receptors (GPCRs) are the most druggable therapeutic…”
Get full text
Journal Article -
10
Ferric Derisomaltose Evaluation in Patients with Non-Dialysis-Dependent Chronic Kidney Disease or Peritoneal Dialysis
Published in Canadian journal of hospital pharmacy (2023)“…Iron deficiency anemia is common in patients with advanced chronic kidney disease (CKD). Ferric derisomaltose (FDI) enables iron repletion in a single dose,…”
Get full text
Journal Article -
11
Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease
Published in The Journal of clinical investigation (01-01-2018)“…Histone protein modifications control fate determination during normal development and dedifferentiation during disease. Here, we set out to determine the…”
Get full text
Journal Article -
12
Ambulatory Medication Reconciliation in Dialysis Patients: Benefits and Community Practitioners' Perspectives
Published in Canadian journal of hospital pharmacy (01-11-2017)“…Ambulatory medication reconciliation can reduce the frequency of medication discrepancies and may also reduce adverse drug events. Patients receiving dialysis…”
Get full text
Journal Article -
13
Renal-Limited Antiglomerular Basement Membrane Disease Related To Alemtuzumab: A Case Report
Published in Canadian journal of kidney health and disease (01-01-2020)“…RATIONALEAlemtuzumab is a monoclonal antibody approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). Many autoimmune-mediated adverse…”
Get full text
Report -
14
Primary Hyperoxaluria Type 1 (PH1) Presenting With End-Stage Kidney Disease and Cutaneous Manifestations in Adulthood: A Case Report
Published in Canadian journal of kidney health and disease (01-01-2021)“…RATIONALEPrimary hyperoxaluria (PH) is a rare autosomal recessive disorder more commonly diagnosed in children or adolescents. Owing to its rarity and…”
Get full text
Report